Literature DB >> 10415581

Three-dimensional in vitro cell culture leads to a marked upregulation of cell function in human hepatocyte cell lines--an important tool for the development of a bioartificial liver machine.

C Selden1, A Shariat, P McCloskey, T Ryder, E Roberts, H Hodgson.   

Abstract

Upregulating hepatocyte function in proliferating human liver cell lines could provide cells for a bio-artificial liver. Ideally, a means of mimicking the biological extracellular matrix with a relatively inert, bio-compatible matrix is required. Alginate encapsulation of primary hepatocytes is biocompatible. This study aimed to characterize cells grown in a 3D configuration in alginate. A human-derived liver cell line encapsulated in 1% alginate was assessed for synthetic and detoxification functions. Secreted proteins measured (e.g., albumin, fibrinogen, alpha-1-antitrypsin etc.) were increased in alginate compared with monolayers. Cytochrome P450 1A1 activity increased three- to fourfold, whilst urea synthesis, undetectable in monolayer cultures, was synthesized by cells in alginate at levels approaching in vivo production. TEM revealed good ultrastructure reminiscent of normal hepatocytes. Alginate promotes 3D colonies of proliferating cells with upregulated liver functions. Rapid recovery of function of cryopreserved cells (< 18 h) provides added advantages for this system to support the biological component of an artificial liver for patients with fulminant hepatic failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10415581     DOI: 10.1111/j.1749-6632.1999.tb08517.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  Encapsulation of Huh-7 cells within alginate-poly(ethylene glycol) hybrid microspheres.

Authors:  Redouan Mahou; Nhu Mai Tran; Murielle Dufresne; Cécile Legallais; Christine Wandrey
Journal:  J Mater Sci Mater Med       Date:  2011-12-09       Impact factor: 3.896

2.  Influence of a three-dimensional, microarray environment on human cell culture in drug screening systems.

Authors:  Luciana Meli; Eric T Jordan; Douglas S Clark; Robert J Linhardt; Jonathan S Dordick
Journal:  Biomaterials       Date:  2012-09-19       Impact factor: 12.479

Review 3.  Systems biology approaches for studying the pathogenesis of non-alcoholic fatty liver disease.

Authors:  Ciarán P Fisher; Andrzej M Kierzek; Nick J Plant; J Bernadette Moore
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

4.  Hepatocyte-like cells derived from human amniotic epithelial cells can be encapsulated without loss of viability or function in vitro.

Authors:  Vijesh Vaghjiani; Vijayaganapathy Vaithilingam; Indah Saraswati; Adnan Sali; Padma Murthi; Bill Kalionis; Bernard E Tuch; Ursula Manuelpillai
Journal:  Stem Cells Dev       Date:  2014-01-21       Impact factor: 3.272

5.  A non-destructive culturing and cell sorting method for cardiomyocytes and neurons using a double alginate layer.

Authors:  Hideyuki Terazono; Hyonchol Kim; Masahito Hayashi; Akihiro Hattori; Fumimasa Nomura; Tomoyuki Kaneko; Kenji Yasuda
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

6.  Efficient generation of hepatoblasts from human ES cells and iPS cells by transient overexpression of homeobox gene HEX.

Authors:  Mitsuru Inamura; Kenji Kawabata; Kazuo Takayama; Katsuhisa Tashiro; Fuminori Sakurai; Kazufumi Katayama; Masashi Toyoda; Hidenori Akutsu; Yoshitaka Miyagawa; Hajime Okita; Nobutaka Kiyokawa; Akihiro Umezawa; Takao Hayakawa; Miho K Furue; Hiroyuki Mizuguchi
Journal:  Mol Ther       Date:  2010-11-23       Impact factor: 11.454

7.  Impact of alginate composition: from bead mechanical properties to encapsulated HepG2/C3A cell activities for in vivo implantation.

Authors:  Stephanie H Capone; Murielle Dufresne; Mathias Rechel; Marie-José Fleury; Anne-Virginie Salsac; Patrick Paullier; Martine Daujat-Chavanieu; Cecile Legallais
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

8.  Bioengineering the liver: scale-up and cool chain delivery of the liver cell biomass for clinical targeting in a bioartificial liver support system.

Authors:  Eloy Erro; James Bundy; Isobel Massie; Sherri-Ann Chalmers; Aude Gautier; Spyridon Gerontas; Mike Hoare; Peter Sharratt; Sarah Choudhury; Marcin Lubowiecki; Ian Llewellyn; Cécile Legallais; Barry Fuller; Humphrey Hodgson; Clare Selden
Journal:  Biores Open Access       Date:  2013-02

9.  Evaluation of encapsulated liver cell spheroids in a fluidised-bed bioartificial liver for treatment of ischaemic acute liver failure in pigs in a translational setting.

Authors:  Clare Selden; Catherine Wendy Spearman; Delawir Kahn; Malcolm Miller; Anthony Figaji; Eloy Erro; James Bundy; Isobel Massie; Sherri-Ann Chalmers; Hiram Arendse; Aude Gautier; Peter Sharratt; Barry Fuller; Humphrey Hodgson
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  A clinical-scale BioArtificial Liver, developed for GMP, improved clinical parameters of liver function in porcine liver failure.

Authors:  Clare Selden; James Bundy; Eloy Erro; Eva Puschmann; Malcolm Miller; Delawir Kahn; Humphrey Hodgson; Barry Fuller; Jordi Gonzalez-Molina; Aurelie Le Lay; Stephanie Gibbons; Sherri Chalmers; Sunil Modi; Amy Thomas; Peter Kilbride; Agnes Isaacs; Richard Ginsburg; Helen Ilsley; David Thomson; Galya Chinnery; Ncedile Mankahla; Lizel Loo; C Wendy Spearman
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.